CGC Financial Services’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.64K Hold
133
– – ﹤0.01% 244
2026
Q2
$3.69K Hold
133
– – ﹤0.01% 275
2026
Q1
$2.87K Hold
133
– – ﹤0.01% 273
2025
Q4
$1.83K Hold
133
– – ﹤0.01% 293
2025
Q3
$2.35K Hold
133
– – ﹤0.01% 286
2025
Q2
$2.01K Hold
133
– – ﹤0.01% 277
2025
Q1
$2.14K Hold
133
– – ﹤0.01% 270
2024
Q4
$2.32K Hold
133
– – ﹤0.01% 274
2024
Q3
$2.33K Hold
133
– – ﹤0.01% 270
2024
Q2
$1.49K Hold
133
– – ﹤0.01% 283
2024
Q1
$1.16K Buy
+133
New +$1.22K ﹤0.01% 301

Other funds holding PLSE

CGC Financial Services's PLSE Position: Q3 2026 in Review

CGC Financial Services held its Pulse Biosciences (PLSE) position steady in Q3 2026 at 133 shares worth $6.64K. The position accounts for ﹤0.01% of the portfolio, ranked #244.

CGC Financial Services first reported a position in PLSE in Q1 2024 and has held it in 11 quarters since. 14 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • CGC Financial Services held 133 shares of Pulse Biosciences worth $6.64K as of Q3 2026.
  • CGC Financial Services left its Pulse Biosciences share count unchanged in Q3 2026.
  • Pulse Biosciences made up ﹤0.01% of CGC Financial Services's portfolio in Q3 2026, its #244 holding.
  • CGC Financial Services first reported a position in Pulse Biosciences in Q1 2024 and has held it in 11 quarters since.
  • 14 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on CGC Financial Services's 13F filing for Q3 2026, filed 13 Oct 2026.